Etoricoxib-induced acute generalized exanthematous pustulosis

Acta Dermato-Venereologica

Volumn 88, Issue 2, 2008, Pages 200-201

  Mäkelä, Leeni ^a   Lammintausta, Kaija ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; CELECOXIB; CLINDAMYCIN; CREATINE; ETORICOXIB; METHYLPREDNISOLONE; PARECOXIB; TETRACYCLINE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; BLOOD EXAMINATION; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MALE; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; ROSACEA; SKIN BIOPSY; SKIN DISEASE; SODIUM BLOOD LEVEL; THORAX RADIOGRAPHY; URINALYSIS;

ACUTE DISEASE; CYCLOOXYGENASE 2 INHIBITORS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EXANTHEMA; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; PYRIDINES; SKIN; SKIN DISEASES, VESICULOBULLOUS; SULFONES;

EID: 41949118908     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0381     Document Type: Letter

References (10)

1. Roujeau J-C, Bioulac-Sage M, Bourseau C, Guillaume JC, Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis. Arch Dermatol 1991; 127: 1333-1338.
2. Padial MA, Alvarez-Ferreira J, Tapia B, Blanco R, Manas S, Blanca M, et al. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol 2004; 150: 139-142.
3. Beltraminelli HS, Lerch M, Arnold A, Bircher AJ and Hausermann P. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: a case report and review of the literature. Br J Dermatol 2005; 152: 780-783.
4. Wolkenstein P, Chosidow O, Flechet ML, Robbiola P, Paul M, Dume L, et al. Patch testing in severe adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-236.
5. Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, et al. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol 2003; 43: 573-585.
6. El Miedany Y, Youssef S, Ahmed I, El Gaafary KM. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2006; 97: 105-109.
7. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase-2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005; 95: 154-158.
8. Teixeira M, Silva E, Selores M. Acute generalized ecanthematous pustulosis induced by nimesulide. Dermatol Online J 2006; 12: 20.
9. Byerly FL, Nelson KC, Granko RP, Morrell DS, Cairns BA. Valdecoxib-associated acute generalized exanthematous pustulosis. Burns 2005; 31: 383-387.
10. Yang CC, Lee JY, Chen WC. Acute generalized exanthematous pustulosis caused by celecoxib. J Formos Med Accoc 2004; 103: 555-557.